While in ERG+ rearranged tumours, the earliest homozygous deletions appeared in region chr5:55-59 Mb in ERG− cancers, losses at chr5:60-100 Mb, covering the well-known affected gene CHD1, were reported. This evidence concerns the gene CHD1 and cancer.